Trial intelligence / Profile preview

Pre-operative Ulipristal for Fibroids in Chinese Population

NCT02825719Phase 4Terminated

Sponsor
Queen Mary Hospital
Start
Dec 2015
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ulipristal in uterine leiomyoma, sponsored by Queen Mary Hospital. Started Dec 2015; status: terminated.

02

Drugs

ulipristal
03

Conditions

uterine leiomyoma

Beyond the preview

Go deeper on NCT02825719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02825719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call